Yearly Archives: 2017

Forge Therapeutics to present at World Anti-Microbial Resistance Congress 2017

San Diego, California, September 12, 2017 – Forge Therapeutics, Inc., (Forge) announced today that the company will present a talk entitled, “Forging new ...

Forge Therapeutics to present at World Anti-Microbial Resistance Congress 20172017-10-04T14:16:36-07:00

Forge Therapeutics and Evotec present efficacy data for LpxC Inhibitor in urinary tract, lung, thigh, and abdominal infection models at ASM ESCMID 2017

San Diego, California, September 7, 2017 – Forge Therapeutics, Inc., (Forge) and its strategic alliance partner Evotec AG (Evotec), announced new preclinical data ...

Forge Therapeutics and Evotec present efficacy data for LpxC Inhibitor in urinary tract, lung, thigh, and abdominal infection models at ASM ESCMID 20172017-10-06T18:31:58-07:00

Forge Therapeutics and Evotec to present preclinical data on novel antibiotic program at 2017 ASM/ESCMID Conference

San Diego, California, August 29, 2017 – Forge Therapeutics, Inc., (Forge) and its strategic alliance partner Evotec AG (Evotec), announced today that the ...

Forge Therapeutics and Evotec to present preclinical data on novel antibiotic program at 2017 ASM/ESCMID Conference2017-10-04T14:17:29-07:00

Forge Therapeutics forms scientific advisory board with world renowned antibiotic and drug development experts

San Diego, California, July 26, 2017 – Forge Therapeutics, Inc., (Forge), a biotechnology company discovering first-in-class antibiotics using a breakthrough drug discovery platform, ...

Forge Therapeutics forms scientific advisory board with world renowned antibiotic and drug development experts2017-10-09T22:00:57-07:00

Forge Therapeutics to present at 2017 Bio International Convention

SAN DIEGO, California, June 12, 2017 – Forge Therapeutics, Inc., (Forge), a biotechnology company discovering first-in-class antibiotics using a breakthrough drug discovery platform, ...

Forge Therapeutics to present at 2017 Bio International Convention2017-10-09T17:02:15-07:00

Forge and Evotec Present First Efficacy Data for LpxC Inhibitor in UTI Model at ASM Microbe 2017

San Diego, California, June 3, 2017 – Forge Therapeutics, Inc., (Forge), a biotechnology company discovering first-in-class antibiotics using a breakthrough drug discovery platform, ...

Forge and Evotec Present First Efficacy Data for LpxC Inhibitor in UTI Model at ASM Microbe 20172017-10-11T16:19:13-07:00
Load More Posts
Go to Top